Showing results (1-10 of 11) with videos related to

Sort By:
Pageof 2
Journal of Medical Economics|July 23, 2014
Healthcare resource use and costs of privately insured patients who switch, discontinue, or persist on anti-muscarinic therapy for overactive bladderJasmina I Ivanova, Eleanor Hayes-Larson, Rachael A Sorg, et al.
Journal of Opioid Management|December 20, 2013
The prevalence and economic impact of prescription opioid-related side effects among patients with chronic noncancer painJasmina I Ivanova, Howard G Birnbaum, Yana Yushkina, et al.
Journal of the American Geriatrics Society|September 14, 2013
Effects of care management and telehealth: a longitudinal analysis using medicare dataLaurence C Baker, Dendy S Macaulay, Rachael A Sorg, et al.
Journal of Comparative Effectiveness Research|July 11, 2015
Comparative efficacy and safety of daclatasvir/asunaprevir versus IFN-based regimens in genotype 1b hepatitis C virus infectionJames E Signorovitch, Keith A Betts, Yan Song, et al.
Journal of Ophthalmic Inflammation and Infection|November 8, 2013
Healthcare costs and utilization for privately insured patients treated for non-infectious uveitis in the USADavid S Chu, Scott J Johnson, Usha G Mallya, et al.
Respiratory Medicine|June 29, 2013
Development and validation of a claims-based prediction model for COPD severityDendy Macaulay, Shawn X Sun, Rachael A Sorg, et al.
Journal of Managed Care & Specialty Pharmacy|March 25, 2015
Treatment patterns, health care resource utilization, and costs in U.S. patients diagnosed with chronic hepatitis C infection who received telaprevir or boceprevirT Kim Le, Anupama Kalsekar, Dendy Macaulay, et al.
Pageof 2